U.S. markets open in 2 hours 30 minutes
  • S&P Futures

    3,426.00
    -6.50 (-0.19%)
     
  • Dow Futures

    28,081.00
    -53.00 (-0.19%)
     
  • Nasdaq Futures

    11,676.75
    -14.50 (-0.12%)
     
  • Russell 2000 Futures

    1,604.90
    +1.80 (+0.11%)
     
  • Crude Oil

    40.27
    +0.24 (+0.60%)
     
  • Gold

    1,920.00
    -9.50 (-0.49%)
     
  • Silver

    25.01
    -0.23 (-0.92%)
     
  • EUR/USD

    1.1836
    -0.0031 (-0.26%)
     
  • 10-Yr Bond

    0.8160
    0.0000 (0.00%)
     
  • Vix

    29.31
    -0.04 (-0.14%)
     
  • GBP/USD

    1.3097
    -0.0046 (-0.35%)
     
  • USD/JPY

    104.6700
    +0.1100 (+0.11%)
     
  • BTC-USD

    12,973.11
    +1,916.10 (+17.33%)
     
  • CMC Crypto 200

    260.94
    +16.05 (+6.55%)
     
  • FTSE 100

    5,773.20
    -3.30 (-0.06%)
     
  • Nikkei 225

    23,474.27
    -165.19 (-0.70%)
     

Rite Aid to Host Analyst Day on March 16, 2020

·1 min read

Rite Aid Corporation (NYSE: RAD) today announced that the executive leadership team will host an Analyst Day on Monday, March 16, 2020 in New York, NY.

The presentation will begin at 9:00 a.m. ET and the simultaneous, live webcast will be available on the Investor Relations section of the Rite Aid’s website at https://www.riteaid.com/corporate/investor-relations/presentations.

About Rite Aid Corporation

Rite Aid Corporation is on the front lines of delivering health care services and retail products to over 1.6 million Americans daily. Our pharmacists are uniquely positioned to engage with customers and improve their health outcomes. We provide an array of whole being health products and services for the entire family through over 2,400 retail pharmacy locations across 18 states. Through EnvisionRxOptions, we also deliver pharmacy benefit management to approximately 1,900 clients and 3.4 million members. For more information, www.riteaid.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005543/en/

Contacts

INVESTORS:
Byron Purcell
(717) 975-5809
investor@riteaid.com

MEDIA:
Christopher Savarese
(717) 975-5718
Christopher.Savarese@riteaid.com